IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q2 2016 Holdings

Filed 2016-08-12 | 20 holdings | $4.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cellectis(CLLS)SPONDS ADR15117K103$2.7M100,00055.6%
Adaptimmune(ADAPY)SPONDS ADR00653A107$2.0M250,00042.5%
ParatekCommon699374302$18.1K1,301,4130.4%
ProteonCommon74371L109$16.3K2,017,8720.3%
SientraCommon82621J105$14.5K2,199,0120.3%
TobiraCommon88883P101$7.4K589,2440.2%
CempraCommon15130J109$6.3K383,9350.1%
Chiasma(CHMA)Common16706W102$6.0K2,080,5950.1%
Lombard MedicalCommonG55598109$3.8K3,473,4520.1%
InnocollSPONDS ADR45780Q103$3.1K555,5550.1%
Dicerna(DRNAUSD)Common253031108$2.8K945,7570.1%
Cymabay(CBAYUSD)Common23257D103$2.8K1,600,0000.1%
Dermira(DERMEUR)Common24983L104$2.0K70,0000.0%
Senseonics(SENS1GBP)Common81727U105$2.0K516,8820.0%
Immune DesignCommon45252L103$1.6K197,3000.0%
Aurinia Pharma(AUPH)Common05156V102$1.4K512,0360.0%
AntheraCommon03674U201$1.3K437,9940.0%
RegulusCommon75915K101$943327,3500.0%
Oncogenex PharmaCommon68230A106$400396,1040.0%
Epirus BiopharmaCommon29428P107$47,8960.0%